LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 49.56 | 21.74 | 19 | 4838 | 0.0039 | -0.0171 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 49.56 | 21.74 | 5488 | 4838 | 1.1342 | 1.0326 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 49.56 | 21.74 | 94 | 4838 | 0.0194 | 0.2065 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 49.56 | 21.74 | 4680 | 4838 | 0.9672 | 0.9915 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 51.53 | 21.74 | 22 | 5150 | 0.0043 | 0.0015 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 51.53 | 21.74 | 5958 | 5150 | 1.1567 | 1.0373 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 51.53 | 21.74 | 104 | 5150 | 0.0202 | 0.2195 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 51.53 | 21.74 | 4994 | 5150 | 0.9696 | 0.9922 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 53.50 | 21.74 | 27 | 5425 | 0.0050 | 0.0276 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 53.50 | 21.74 | 6508 | 5425 | 1.1994 | 1.0462 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 53.50 | 21.74 | 105 | 5425 | 0.0194 | 0.2187 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 53.50 | 21.74 | 5367 | 5425 | 0.9892 | 0.9973 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 55.48 | 21.74 | 24 | 5768 | 0.0042 | 0.0124 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 55.48 | 21.74 | 6995 | 5768 | 1.2126 | 1.0485 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 55.48 | 21.74 | 93 | 5768 | 0.0161 | 0.1978 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 55.48 | 21.74 | 5680 | 5768 | 0.9846 | 0.9962 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 57.45 | 21.74 | 14 | 6023 | 0.0023 | -0.0528 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 57.45 | 21.74 | 7562 | 6023 | 1.2554 | 1.0569 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 57.45 | 21.74 | 106 | 6023 | 0.0176 | 0.2156 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 57.45 | 21.74 | 6088 | 6023 | 1.0107 | 1.0026 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 59.42 | 21.74 | 9 | 6125 | 0.0015 | -0.1027 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 59.42 | 21.74 | 7895 | 6125 | 1.2889 | 1.0634 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 59.42 | 21.74 | 115 | 6125 | 0.0188 | 0.2271 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 59.42 | 21.74 | 6510 | 6125 | 1.0628 | 1.0150 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 62.39 | 21.74 | 6 | 6112 | 0.0010 | -0.1464 | MN20160310_N01 | L18 |